EurekAlert! -
2 Feb 2017 07:00
(NIH/National Institute of Allergy and Infectious Diseases) A novel, gene-based investigational vaccine protected mice and monkeys against Zika virus infection after a single dose, according to a study appearing online in the journal Nature on Feb. 2. The candidate vaccine iscalled ZIKV prM-E mRNA-LNP. Scientists at the University of Pennsylvania in Philadelphia and at the company BioNTech in Mainz, Germany, developed the vaccine. The research was conducted by investigators funded by NIAID, NIAI...
Share this Article